HIV-1 Nef Dimerization Is Required for Nef-Mediated Receptor Downregulation and Viral Replication

Journal of Molecular Biology

Volumn 394, Issue 2, 2009, Pages 329-342

  Poe, Jerrod A ^a   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

bimolecular fluorescence complementation; CD4; dimerization; HIV Nef; HIV replication

Indexed keywords

ANTIRETROVIRUS AGENT; HOMODIMER; NEF PROTEIN; OLIGOMER; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; DISEASE COURSE; DRUG DESIGN; DRUG TARGETING; ELECTRICITY; FLUORESCENCE; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; TRANS GOLGI NETWORK; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350547756     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.09.047     Document Type: Article

References (71)

1. Kestler H., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high viral loads and for development of AIDS. Cell 65 (1991) 651-662
2. Bonyhadi M.L., Rabin L., Salimi S., Brown D.A., Kosek J., McCune J.M., and Kaneshima H. HIV induces thymus depletion in vivo. Nature 363 (1993) 728-732
3. Hanna Z., Kay D.G., Rebai N., Guimond A., Jothy S., and Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 (1998) 163-175
4. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 (1995) 988-991
5. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 (1995) 228-232
6. Alexander L., Du Z., Rosenzweig M., Jung J.U., and Desrosiers R.C. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 Nef alleles in lymphocyte activation. J. Virol. 71 (1997) 6094-6099
7. Fackler O.T., and Baur A.S. Live and let die: Nef functions beyond HIV replication. Immunity 16 (2002) 493-497
8. Simmons A., Aluvihare V., and McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14 (2001) 763-777
9. Baur A.S., Sawai E.T., Dazin P., Fantl W.J., Cheng-Mayer C., and Peterlin B.M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1 (1994) 373-384
10. Iafrate A.J., Bronson S., and Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16 (1997) 673-684
11. + viruses but not for down-regulation of CD4. EMBO J. 14 (1995) 484-491
12. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71 (1997) 5871-5877
13. Chowers M.Y., Spina C.A., Kwoh T.J., Fitch N.J., Richman D.D., and Guatelli J.C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68 (1994) 2906-2914
14. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., and Feinberg M.B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179 (1994) 101-113
15. Schwartz O., Dautry-Varsat A., Goud B., Marechal V., Subtil A., Heard J.M., and Danos O. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69 (1995) 528-533
16. Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.H., and Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111 (2002) 853-866
17. Hung C.H., Thomas L., Ruby C.E., Atkins K.M., Morris N.P., Knight Z.A., et al. HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell Host Microbe 1 (2007) 121-133
18. Piguet V., and Trono D. Living in oblivion: HIV immune evasion. Semin. Immunol. 13 (2001) 51-57
19. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 (1998) 397-401
20. Anderson S., Shugars D.C., Swanstrom R., and Garcia J.V. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67 (1993) 4923-4931
21. Benson R.E., Sanfridson A., Ottinger J.S., Doyle C., and Cullen B.R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177 (1993) 1561-1566
22. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 (1991) 508-511
23. Mariani R., and Skowronski J. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc. Natl Acad. Sci. USA 90 (1993) 5549-5553
24. Lama J., Mangasarian A., and Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 (1999) 622-631
25. Ross T.M., Oran A.E., and Cullen B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9 (1999) 613-621
26. Cortes M.J., Wong-Staal F., and Lama J. Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J. Biol. Chem. 277 (2002) 1770-1779
27. Marshall W.L., Diamond D.C., Kowalski M.M., and Finberg R.W. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. J. Virol. 66 (1992) 5492-5499
28. Das S.R., and Jameel S. Biology of the HIV Nef protein. Indian J. Med. Res. 121 (2005) 315-332
29. Foster J.L., and Garcia J.V. HIV-1 Nef: at the crossroads. Retrovirology 5 (2008) 84
30. Aiken C., and Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69 (1995) 5048-5056
31. Arold S., Franken P., Strub M.P., Hoh F., Benichou S., Benarous R., and Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5 (1997) 1361-1372
32. Geyer M., Fackler O.T., and Peterlin B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2 (2001) 580-585
33. Lee C.-H., Saksela K., Mirza U.A., Chait B.T., and Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85 (1996) 931-942
34. Liu L.X., Heveker N., Fackler O.T., Arold S., Le Gall S., Janvier K., et al. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J. Virol. 74 (2000) 5310-5319
35. Williams M., Roeth J.F., Kasper M.R., Filzen T.M., and Collins K.L. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79 (2005) 632-636
36. Ye H., Choi H.J., Poe J., and Smithgall T.E. Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry 43 (2004) 15775-15784
37. Choi H.J., and Smithgall T.E. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J. Mol. Biol. 343 (2004) 1255-1268
38. Shyu Y.J., Liu H., Deng X., and Hu C.D. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. BioTechniques 40 (2006) 61-66
39. Breuer S., Gerlach H., Kolaric B., Urbanke C., Opitz N., and Geyer M. Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef. Biochemistry 45 (2006) 2339-2349
40. Geyer M., and Peterlin B.M. Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett. 496 (2001) 91-95
41. Arold S., O'Brien R., Franken P., Strub M.P., Hoh F., Dumas C., and Ladbury J.E. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 37 (1998) 14683-14691
42. Grzesiek S., Bax A., Clore G.M., Gronenborn A.M., Hu J.-S., Kaufman J., et al. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3 (1996) 340-345
43. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., and Trono D. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2 (2000) 163-167
44. Williams M., Roeth J.F., Kasper M.R., Fleis R.I., Przybycin C.G., and Collins K.L. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76 (2002) 12173-12184
45. Bentham M., Mazaleyrat S., and Harris M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87 (2006) 563-571
46. Lee C.-H., Leung B., Lemmon M.A., Zheng J., Cowburn D., Kuriyan J., and Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14 (1995) 5006-5015
47. Hassaine G., Courcoul M., Bessou G., Barthalay Y., Picard C., Olive D., et al. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J. Biol. Chem. 276 (2001) 16885-16893
48. Schreiner S.J., Schiavone A.P., and Smithgall T.E. Activation of Stat3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 277 (2002) 45680-45687
49. Glushakova S., Munch J., Carl S., Greenough T.C., Sullivan J.L., Margolis L., and Kirchhoff F. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 75 (2001) 10113-10117
50. Lundquist C.A., Tobiume M., Zhou J., Unutmaz D., and Aiken C. Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 76 (2002) 4625-4633
51. Green L.A., Liu Y., and He J.J. Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy. J. Biol. Chem. 284 (2009) 13363-13372
52. Salvatori F., and Scarlatti G. HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res. Hum. Retroviruses 17 (2001) 925-935
53. Trkola A., Ketas T., Kewalramani V.N., Endorf F., Binley J.M., Katinger H., et al. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72 (1998) 1876-1885
54. Bracha-Drori K., Shichrur K., Katz A., Oliva M., Angelovici R., Yalovsky S., and Ohad N. Detection of protein-protein interactions in plants using bimolecular fluorescence complementation. Plant J. 40 (2004) 419-427
55. Grinberg A.V., Hu C.D., and Kerppola T.K. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol. Cell. Biol. 24 (2004) 4294-4308
56. Hynes T.R., Tang L., Mervine S.M., Sabo J.L., Yost E.A., Devreotes P.N., and Berlot C.H. Visualization of G protein betagamma dimers using bimolecular fluorescence complementation demonstrates roles for both beta and gamma in subcellular targeting. J. Biol. Chem. 279 (2004) 30279-30286
57. Morell M., Espargaro A., Aviles F.X., and Ventura S. Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case. Proteomics 7 (2007) 1023-1036
58. Matsubara M., Jing T., Kawamura K., Shimojo N., Titani K., Hashimoto K., and Hayashi N. Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci. 14 (2005) 494-503
59. Wang J.K., Kiyokawa E., Verdin E., and Trono D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl Acad. Sci. USA 97 (2000) 394-399
60. Arold S., Hoh F., Domergue S., Birck C., Delsuc M.A., Jullien M., and Dumas C. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci. 9 (2000) 1137-1148
61. Collette Y., Dutartre H., Benziane A., Ramos-Morales F., Benarous R., Harris M., and Olive D. Physical and functional interaction of Nef with Lck-HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271 (1996) 6333-6341
62. Renkema G.H., and Saksela K. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5 (2000) D268-D283
63. Fackler O.T., Luo W., Geyer M., Alberts A.S., and Peterlin B.M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3 (1999) 729-739
64. Sawai E.T., Baur A.S., Peterlin B.M., Levy J.A., and Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270 (1995) 15307-15314
65. Hu C.D., Chinenov Y., and Kerppola T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9 (2002) 789-798
66. Crotti A., Neri F., Corti D., Ghezzi S., Heltai S., Baur A., et al. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation. J. Virol. 80 (2006) 10663-10674
67. Fackler O.T., Moris A., Tibroni N., Giese S.I., Glass B., Schwartz O., and Krausslich H.G. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351 (2006) 322-339
68. Briggs S.D., Scholtz B., Jacque J.M., Swingler S., Stevenson M., and Smithgall T.E. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J. Biol. Chem. 276 (2001) 25605-25611
69. Hiatt S.M., Shyu Y.J., Duren H.M., and Hu C.D. Bimolecular fluorescence complementation (BiFC) analysis of protein interactions in Caenorhabditis elegans. Methods 45 (2008) 185-191
70. Muller A.J., Young J.C., Pendergast A.M., Pondel M., Landau R.N., Littman D.R., and Witte O.N. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11 (1991) 1785-1792
71. Trible R.P., Emert-Sedlak L., Wales T.E., Ayyavoo V., Engen J.R., and Smithgall T.E. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor. J. Mol. Biol. 374 (2007) 121-129